SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001437749-23-008044 from cbdMD, Inc. (YCBD)

cbdMD, Inc.
Date: March 27, 2023 · CIK: 0001644903 · Accession: 0001437749-23-008044

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-270502

Date
March 27, 2023
Author
/s/ T. Ronan Kennedy
Form
CORRESP
Company
cbdMD, Inc.

Letter

ycbd20230323_corresp.htm

cbdMD, Inc.

8845 Red Oak Boulevard

Charlotte, North Carolina 28217

Writer’s Direct Line (919) 641-8759

'CORRESP'

March 27, 2023

Office of Life Sciences

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street N.E.

Washington, DC 20549

Attention: Benjamin Richie

Division of Corporation Finance

Office of Industrial Applications and Services

Re:

cbdMD, Inc. (the "Company")

Registration Statement on Form S-1

Filed March 13, 2023

File No. 333-270502

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to Wednesday, March 29, 2023, at 5:00 p.m., Eastern time, or as soon thereafter as practicable. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Securities Act.

Once the Registration Statement is effective, please orally confirm the event with our counsel Nason, Yeager, Gerson, Harris & Fumero, P.A. by calling Brian Pearlman, Esq. at (954) 880-9484.

Thank you.

Sincerely,
/s/ T. Ronan Kennedy

Show Raw Text
CORRESP
1
filename1.htm

	ycbd20230323_corresp.htm

cbdMD, Inc.

8845 Red Oak Boulevard

Charlotte, North Carolina 28217

Writer’s Direct Line (919) 641-8759

'CORRESP'

			March 27, 2023

Office of Life Sciences

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street N.E.

Washington, DC 20549

			Attention:
			Benjamin Richie

			Division of Corporation Finance

			Office of Industrial Applications and Services

			Re:

			cbdMD, Inc. (the "Company")

Registration Statement on Form S-1

Filed March 13, 2023

File No. 333-270502

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to Wednesday, March 29, 2023, at 5:00 p.m., Eastern time, or as soon thereafter as practicable. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Securities Act.

Once the Registration Statement is effective, please orally confirm the event with our counsel Nason, Yeager, Gerson, Harris & Fumero, P.A. by calling Brian Pearlman, Esq. at (954) 880-9484.

			Thank you.

			Sincerely,

			/s/ T. Ronan Kennedy

			T. Ronan Kennedy

			Interim Chief Executive Officer and

			Chief Financial Officer

			cc:

			Brian Pearlman, Esq., Nason Yeager Gerson Harris & Fumero, P.A.

Brian Bernstein, Esq., Nason Yeager Gerson Harris & Fumero, P.A.